Status:
COMPLETED
A New Supplement for the "Metabolic Syndrome"
Lead Sponsor:
University of Messina
Conditions:
Metabolic Syndrome
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
This study evaluates the effect of a combination of glycirrhizic acid, Cinnamomun Zeylanicum and corosolic acid for the treatment of metabolic syndrome. Participants receive the supplement or a placeb...
Detailed Description
The supplement is composed by of a combination of glycirrhizic acid, Cinnamomun Zeylanicum and corosolic acid. They act in different way reducing insulin resistance, which is the main cause of metabol...
Eligibility Criteria
Inclusion
- Postmenopausal women affected by Metabolic Syndrome, diagnosed by ATP 2015 criteria.
- \-
Exclusion
- treatment with steroids or with hypoglycemic or anti-cholesterol drugs
- \-
Key Trial Info
Start Date :
January 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03813914
Start Date
January 15 2017
End Date
June 30 2018
Last Update
January 23 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.